These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5975303)

  • 1. [Symposium on the open negative syndrome. 2. Formation of the open negative cavity during the course of original treatment and the fate of the cavity].
    Miyagi Y
    Kekkaku; 1966 Aug; 41(8):375-8. PubMed ID: 5975303
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the prognosis of cases with open negative cavity developing mainly due to therapy with primary antituberculosis drugs.
    Fujioka K; Yoshida F; Kawamoto H; Takahashi O; Nishiyama K; Hidaka O
    Jpn J Tuberc; 1966 Dec; 13():Suppl:65-70. PubMed ID: 5298481
    [No Abstract]   [Full Text] [Related]  

  • 3. "Open-negative" syndrome. Clinical course of its development and subsequent destiny.
    Miyagi Y
    Jpn J Tuberc; 1966 Dec; 13():Suppl:54-9. PubMed ID: 5298479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symposium on the open negative syndrome. 4. Study on the prognosis of the open negative syndrome occurring after chemotherapy with primary anti-tuberculous drugs].
    Fujioka M; Yoshida F; Komoto H; Takahashi O; Nishiyama K
    Kekkaku; 1966 Aug; 41(8):381-3. PubMed ID: 5975305
    [No Abstract]   [Full Text] [Related]  

  • 5. [Symposium on the open negative syndrome. 5. Studies on the open negative syndrome occurring after chemotherapy with secondary antituberculous drugs].
    Kimura Y
    Kekkaku; 1966 Aug; 41(8):383-6. PubMed ID: 5975306
    [No Abstract]   [Full Text] [Related]  

  • 6. [Follow-up observation on open negative cases].
    Taga M; Yamamoto M; Hirose H; Katayama A; Matsumoto M
    Kekkaku; 1967 Jan; 42(1):9-14. PubMed ID: 6036571
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fate of patients with "open negative" syndrome].
    Frenkel S; Wójcik B; Jaworski J
    Gruzlica; 1968 May; 36(5):451-4. PubMed ID: 5660491
    [No Abstract]   [Full Text] [Related]  

  • 8. [Syndrome of "open cavity healing". (Analysis of late results of treatment)].
    Zierski M
    Gruzlica; 1967 Mar; 35(3):219-26. PubMed ID: 6041224
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the open negative syndrome resulting from chemotherapy with secondary anti-tuberculosis agents.
    Kimura Y
    Jpn J Tuberc; 1966 Dec; 13():Suppl:71-6. PubMed ID: 5298482
    [No Abstract]   [Full Text] [Related]  

  • 10. [Symposium on the open negative syndrome. 9. Summary of answers to inquiries on indications for the treatment of open negative cases].
    Iwasaki T
    Kekkaku; 1966 Aug; 41(8):392. PubMed ID: 5975310
    [No Abstract]   [Full Text] [Related]  

  • 11. [Course of so-called inactive pulmonary tuberculosis during the 5-years observation].
    Krakowska M
    Gruzlica; 1966 Oct; 34(10):861-5. PubMed ID: 5976984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Symposium on open negative syndrome. 10. Summary].
    Iwasaki T
    Kekkaku; 1966 Aug; 41(8):392-4. PubMed ID: 5975311
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of bacteriological examinations of tissue specimens from patients dead of tuberculosis. Attempt at evaluation of treatment failures].
    Owsiński J; Korlakowski J
    Gruzlica; 1971 Aug; 39(8):774-82. PubMed ID: 5097538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fate of patients discharged from the hospital with cavity in the lung after several months of antitubercular chemotherapy].
    Kochnowski G
    Gruzlica; 1967 May; 35(5):435-9. PubMed ID: 6056257
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphology of pulmonary tuberculosis following systematic long term antibacterial therapy].
    Vavilin GI; Raskina ES
    Probl Tuberk; 1969; 47(4):48-52. PubMed ID: 5368445
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histopathomorphosis of tuberculous lesions in the lungs in the course of chronic tuberculosis treated with antituberculous drugs].
    Szymańska D
    Patol Pol; 1972; 23(3):351-62. PubMed ID: 5072526
    [No Abstract]   [Full Text] [Related]  

  • 18. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb; 59(2):81-9. PubMed ID: 6379258
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa.
    Winqvist N; Nauclér A; Gomes V; Djamanca I; Koivula T; Jensen H; Dias F; Biberfeld G; Källenius G; Norberg R
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):845-52. PubMed ID: 10985653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology and clinical features of pulmonary tuberculosis in southern Costa Brava. Prospective study].
    Casamitja Sot MT; Acero Fernández D; Rubio Goday M
    Rev Sanid Hig Publica (Madr); 1983; 57(1-2):65-74. PubMed ID: 6608134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.